CN Stock MarketDetailed Quotes

000513 Livzon Pharmaceutical Group Inc.

Watchlist
  • 38.05
  • -0.60-1.55%
Market Closed Dec 13 15:00 CST
35.30BMarket Cap17.44P/E (TTM)

Livzon Pharmaceutical Group Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Livzon Pharmaceutical Group Inc. FY2024 9-Month Earnings Date

Currency：CNYOct 23, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
9.08B
--
-5.94%
EPS
--
1.81
--
+5.23%
Analyst Rating
Strong Buy

Dec 13, 2024

Livzon Pharmaceutical Group Inc. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.524B--
--2024/Q4-- / 2.774B--
--2024/Q32.799B / 3.252B--
--2024/Q23.040B / 3.207B--
--2024/Q13.243B / 3.357B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.524B--
--2024/Q4-- / 2.774B--
--2024/Q32.799B / 3.252B--
--2024/Q23.040B / 3.207B--
--2024/Q13.243B / 3.357B--

Unlock Free Earnings Estimates

Livzon Pharmaceutical Group Inc. Earnings Reports

  • Livingstone Group: Report for the third quarter of 2024

    Oct 23 12:00 ET

  • Livzon Pharmaceutical Group Inc.: Half-year report for the year 2024.

    Aug 22 12:00 ET

  • Livzon Pharmaceutical Group Inc.: Summary of Half-Year Report in 2024.

    Aug 22 12:00 ET

  • Livingstone Group: Report for the first quarter of 2024

    Apr 23 12:00 ET

    • Read more

    Top CN Stock Gainers
    Symbol Price % Chg
    KAYO MOTOR
    834058
    38.58 +29.99%
    Zhejiang Zoenn Design
    300901
    14.86 +20.03%
    Zhejiang Meorient Commerce & Exhibition Inc.
    300795
    22.36 +20.02%
    Fujian Zitian Media Technology
    300280
    22.18 +20.02%
    Zhejiang Prulde Electric Appliance
    301353
    36.46 +20.01%

    See the daily top gainer.

    Analysis

    Analyst Rating

    Updated: Dec 13, 2024

    Strong Buy

    • Strong Buy

      84.62%

    • Buy

      15.39%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Investment Theme Participate in the New Third Board
    Participate in the New Third Board
    Intraday-1.71%
    AH Stocks
    AH Stocks
    Intraday-1.75%
    Monoclonal Antibody Concept
    Monoclonal Antibody Concept
    Intraday-1.90%